Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high Burden setting

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Theron, Grant ^a   Peter, Jonny ^a   Lenders, Laura ^a   van Zyl Smit, Richard ^a   Meldau, Richard ^a   Govender, Ureshnie ^a   Dheda, Keertan ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CULTURE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATHOGEN LOAD; PROGNOSIS; QUANTITATIVE ANALYSIS; SOUTH AFRICA; T LYMPHOCYTE; TH1 CELL; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL LOAD; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TH1 CELLS; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 84861302838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037436     Document Type: Article

References (47)

1. Horne DJ, Royce SE, Gooze L, Narita M, Hopewell PC, et al. (2010) Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. The Lancet infectious diseases 10: 387-394.
2. Lalvani A, (2004) Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clinical Infectious Diseases 38: 757.
3. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, et al. (2011) Predictive value of interferon-[gamma] release assays for incident active tuberculosis: a systematic review and meta-analysis. The Lancet Infectious Diseases.
4. WHO, (2011) Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis. Publication number WHO/HTM/TB/2011. World Health Organization, Geneva, Switzerland.
5. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, et al. (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes 56: 230.
6. Pai M, Zwerling A, Menzies D, (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Annals of Internal Medicine 149: 177.
7. Pai M, Riley LW, Colford JM, (2004) Interferon-[gamma] assays in the immunodiagnosis of tuberculosis: a systematic review. The Lancet infectious diseases 4: 761-776.
8. Ling DI, Pai M, Davids V, Brunet L, Lenders L, et al. (2011) Are interferon- release assays useful for active tuberculosis in a high-burden setting? European Respiratory Journal.
9. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, et al. (2011) Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. European Respiratory Journal 37: 88.
10. Oni T, Patel J, Gideon HP, Seldon R, Wood K, et al. (2010) Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT. TB and CD4 counts. European Respiratory Journal 36: 594-600.
11. Daniel TM, Oxtoby M, Pinto E, Moreno E, (1981) The immune spectrum in patients with pulmonary tuberculosis. The American review of respiratory disease 123: 556.
12. Hill PC, Fox A, Jeffries DJ, Jackson-Sillah D, Lugos MD, et al. (2005) Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clinical Infectious Diseases 40: 273.
13. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, et al. (2002) Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. Journal of Clinical Microbiology 40: 704.
14. Sauzullo I, Mengoni F, Lichtner M, Massetti AP, Rossi R, et al. (2009) In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-γ T cell response. PloS one 4: e5187.
15. Dheda K, Pooran A, Pai M, Miller R, Lesley K, et al. (2007) Interpretation of Mycobacterium tuberculosis antigen-specific IFN-[gamma] release assays (T-SPOT. TB) and factors that may modulate test results. Journal of Infection 55: 169-173.
16. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, et al. (2004) Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clinical Infectious Diseases 38: 754.
17. Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, et al. (2007) Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 35: 98-103.
18. Al-Attiyah R, Mustafa A, Abal A, Madi N, Andersen P, (2003) Restoration of mycobacterial antigen-induced proliferation and interferon-γ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunology and Medical Microbiology 38: 249-256.
19. Wu-Hsieh BA, Chen CK, Chang JH, Lai SY, Wu C, et al. (2001) Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clinical Infectious Diseases 33: 1336.
20. Ferrand R, Bothamley G, Whelan A, Dockrell H, (2005) Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. The International Journal of Tuberculosis and Lung Disease 9: 1034-1039.
21. Ribeiro S, Dooley K, Hackman J, Loredo C, Efron A, et al. (2009) T-SPOT. TB responses during treatment of pulmonary tuberculosis. BMC infectious diseases 9: 23.
22. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, et al. (2007) Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS medicine 4: e192.
23. Bocchino M, Chairadonna P, Matarese A, Bruzzese D, Salvatores M, et al. (2010) Limited usefulness of QuantiFERON-TB Gold In-Tube® for monitoring anti-tuberculosis therapy. Respiratory Medicine 104: 1551-1556.
24. Lee SW, Lee CT, Yim JJ, (2010) Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC infectious diseases 10: 300.
25. Adetifa IMO, Ota MOC, Walther B, Hammond AS, Lugos MD, et al. (2010) Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases. PloS one 5: e12502.
26. WHO, (2011) Rapid Implementation of the Xpert MTB/RIF diagnostic test. Publication number WHO/HTM/TB/2011.2. World Health Organization, Geneva, Switzerland.
27. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, et al. (2011) Evaluation of the Xpert (R) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. American Journal of Respiratory and Critical Care Medicine pp. 201101-200056OCv201101.
28. Dawson R, Masuka P, Edwards D, Bateman E, Bekker L, et al. (2010) Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis 14: 52-58.
29. Den Boon S, Bateman E, Enarson D, Borgdorff M, Verver S, et al. (2005) Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. The International Journal of Tuberculosis and Lung Disease 9: 1088-1096.
30. Theron G, Pinto L, Peter J, Mishra HK, van Zyl-Smit R, et al. (2011) The Use of An Automated Quantitative Polymerase Chain Reaction (Xpert MTB/RIF) to Predict the Sputum Smear Status of Tuberculosis Patients. Clinical Infectious Diseases.
31. Theron G, Pooran A, Peter J, van Zyl-Smit R, Mishra H, et al. (2011) Do adjunct TB tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? European Respiratory Journal.
32. Dheda K, van Zyl-Smit RN, Meldau R, Meldau S, Symons G, et al. (2009) Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax 64: 847.
33. Sullivan K, Dean A, Minn minn S, (2009) OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Reports 124: 471-474.
34. Perrin F, Woodward N, Phillips P, McHugh T, Nunn A, et al. (2010) Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease 14: 1596-1602.
35. Schwander S, Dheda K, (2011) Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. American Journal of Respiratory and Critical Care Medicine 183: 696.
36. Dheda K, Schwander SK, Zhu B, Van ZYL-SMIT RN, Zhang Y, (2010) The immunology of tuberculosis: from bench to bedside. Respirology 15: 433-450.
37. GG G, Locht C, (2011) Recombinant HBHA Boosting Effect on BCG-Induced Immunity against Mycobacterium tuberculosis Infection. Clinical and Developmental Immunology 2011.
38. Pethe K, Alonso S, Biet F, Delogu G, Brennan MJ, et al. (2001) The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412: 190-194.
39. Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, et al. (2011) Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PloS one 6: e18315.
40. Hougardy JM, Hildebrand M, Drowart A, Debrie AS, Locht C, et al. (2007) Regulatory T cells depress immune responses to protective antigens in active tuberculosis. American Journal of Respiratory and Critical Care Medicine 176: 409-416.
41. Basirudeen K, Alamelu R, Balambal R, Satheesh T, Marc L, et al. (2011) IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infectious Diseases 11.
42. Hesseling A, Walzl G, Enarson D, Carroll N, Duncan K, et al. (2010) Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. The International Journal of Tuberculosis and Lung Disease 14: 560-570.
43. Visser ME, Stead MC, Walzl G, Warren R, Schomaker M, et al. (2012) Baseline Predictors of Sputum Culture Conversion in Pulmonary Tuberculosis: Importance of Cavities, Smoking, Time to Detection and W-Beijing Genotype. PloS one 7: e29588.
44. Diacon A, Maritz J, Venter A, Van Helden P, Andries K, et al. (2010) Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. European Journal of Clinical Microbiology and Infectious Diseases pp. 1-5.
45. Bark CM, Thiel BA, Johnson JL, (2012) Pretreatment Time to Detection of Mycobacterium tuberculosis in Liquid Culture Is Associated with Relapse after Therapy. Journal of Clinical Microbiology 50: 538-538.
46. Franken W, Arend S, Thijsen S, Bouwman J, Koster B, et al. (2008) Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts. The International Journal of Tuberculosis and Lung Disease 12: 1286-1294.
47. Moure R, Munoz L, Torres M, Santin M, Martín R, et al. (2011) Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. Journal of Clinical Microbiology 49: 1137-1139.